The present invention relates to apparatus and methods used to prevent the introduction of emboli into the bloodstream during and after surgery performed to reduce or remove blockage in blood vessels.
Narrowing or occlusion of blood vessels, such as the walls of an artery, inhibits normal blood flow. Such blockages, whether partial or full, can have serious medical consequences, depending upon their location within a patient's vascular system. Narrowing or blockage of the coronary vessels that supply blood to the heart, a condition known as atherosclerosis, may cause damage to the heart. Heart attacks (myocardial infarction) may also result from this condition. Other vessels are also prone to narrowing, including carotids, renals, cerebrals, and other peripheral arteries.
Various surgical procedures are currently used to reduce or remove the blockage in blood vessels. Such procedures include balloon angioplasty, which involves inserting a balloon catheter into the narrowed or occluded area, expanding the balloon in the narrow or occluded area, and if necessary, placing a stent in the now expanded area to keep it open. Another common procedure used is atherectomy where the lesion is cut away and removed from the vessel, or abrasively ground, sending the small particulates downstream. Other endovascular procedures make use of thrombectomy, drug delivery, radiation, stent-grafts, and various diagnostic devices.
Another alternative is bypass surgery in which a section of vein is removed from, for example, the patient's leg, e.g., a saphenous vein, to be used as a graft to form a pathway to bypass the occluded area. The saphenous vein graft (SVG), however, is also susceptible to becoming occluded in a manner similar to that of the bypassed vessel. In such a case, angioplasty (with or without the use of a stent) or atherectomy is often used on the SVG to remove or reduce the blockage.
Each of the above described procedures carries with it the risk that some of the treated plaque, or other obstructive material such as thrombus, will be disrupted, resulting in embolic particulates released in the bloodstream. These emboli, if allowed to flow through the vascular system, may cause subsequent infarctions or ischemia in the patient. SVGs treated by angioplasty or atherectomy carry a particularly high risk of this result, but such problems are also encountered in the other types of procedures mentioned, such as carotids, or native coronary arteries, particularly those whose lesions include thrombus, such as those associated with acute myocardial infarction (AMI).
Several systems to prevent emboli being released into the bloodstream during such procedures have been tried. One system uses a balloon to totally occlude the artery distal (downstream) to the area of blockage to be treated. In this system, a guide wire with a balloon is introduced into the narrowed or occluded area, and passes through the narrowed or occluded area to a position downstream of the blockage. The balloon is inflated, the blockage is reduced or removed, and then the blood proximal to the balloon is withdrawn from the blood vessel to remove any particles or emboli which have resulted from the reduction of the blockage. While this system has shown a decrease in emboli related complications in patients undergoing such treatments, the event rate remains significant. One particular problem with this system is passing the guidewire and balloon through the narrowed or occluded area prior to occlusion with the balloon, creating the risk that emboli will be produced as the balloon passes through the blockage. Thus, any particulate or plaque disturbed during this passage which forms emboli prior to inflation of the balloon is free to flow through the vascular system, increasing the risk for infarction or ischemia. Also, any debris or embolic particulate matter which gathers around the edges of the balloon may slip downstream during deflation and retrieval of the balloon. In addition, this system requires that blood flow be totally occluded in the vessel for relatively prolonged intervals that may induce adverse cardiac events. Although this may not be a problem clinically, many patients perceive the occlusion of blood flow for this period of time as problematic.
Another system used to prevent emboli being released into the bloodstream during surgical intervention is a filter. As with the occlusion balloon, the filter must pass through the narrowed or occluded area and is deployed distal (downstream) to the blockage. The filter then catches any particulate material generated during the removal of the blockage. The filter offers the benefit that blood flow is not totally occluded. However, because the filter must pass through the blockage, it suffers from the same drawback as the previous system—risk of the creation of emboli during passage of the filter through the blockage. In addition, it is difficult to deploy the filter securely against the walls of the vessel to prevent flow around the filter and any debris or particulate matter which gathers around the edges of the filter may slip downstream during its retrieval. Also, in order to allow blood flow during the procedure, the pores of the filter should be at least 100 microns in diameter. The majority of emboli have a diameter between about 40 microns and about 100 microns. Thus, the filter will not catch the majority of emboli, which may flow downstream and cause an infarction or ischemia. The filter also cannot prevent the passage of certain neurohumoral or vasoactive substances which are released into the blood during the procedure and may contribute to generalized vasospasm of the distal coronary tree.
Thus, there is a need for an improved system and method of treating occluded vessels which can reduce the risk of distal embolization during vascular interventions. There is also a need for a system which reduces the amount of time that total occlusion of the blood flow is necessary.
In accordance with the invention, methods and apparatuses for reducing or removing a blockage within a vessel without permitting embolization of particulate matter are provided. The methods and apparatuses occlude blood flow for a minimal amount of time and capture particulate matter created during each step of the surgical process.
According to one aspect of the present invention, an evacuation sheath assembly is provided. The evacuation sheath assembly includes a first elongate tubular member having main lumen, wherein the main lumen is configured to be placed in fluid communication with the blood stream so that embolic particulate matter may be evacuated, contrast, saline or other therapeutic fluid may be infused or interventional devices may be delivered to a blood vessel. The evacuation sheath further includes an expandable sealing member configured to form a seal with a blood vessel and a second elongate tubular member with distal and proximal ends and an inflation lumen extending therebetween, wherein the inflation lumen is configured to be placed in fluid communication with the expandable member at the distal end. The evacuation sheath further includes gas inflator having a pressure regulating mechanism, wherein the gas inflator is configured to be connected to the proximal end of the inflation lumen to deliver provide a regulated pressure gas source for inflating the expandable member. The expandable member may be a balloon, alternatively the expandable member may be any suitable expandable sealing member.
In an alternative embodiment, the evacuation sheath assembly may further include a soft tip mounted on the distal end of the first elongate tubular member. Such a soft tip may further be secured to the distal end of first elongate tubular member and the distal end of the expandable member in order to provide a flexible, conical shape capable of can deforming and dilating to facilitate folding up a “winged out” balloon of an interventional device as it is withdrawn back through the main lumen of the evacuation sheath.
In an alternate embodiment, the first elongate tubular member may further be surrounded by a kink resistant structure, for example a kink resistant braid or a kink resistant coil. The kink resistant coil may be comprised of a ribbon wire and may have further be secured at the proximal and distal ends of the coil to prevent uncoiling by one or more laser welds joining one or more adjacent turns of the coil. In such an embodiment, the second elongate tubular member may then be secured to the first elongate member by mounting the second elongate tubular member to the kink resistant structure.
In addition, it is further contemplated that the second elongate tubular member and the first elongate tubular member surrounded by the kink resistant coil may further be enclosed by an encapsulation layer. The encapsulation layer may be made of PEBAX or another suitable material. The encapsulation layer may then be melted down to conform and bond to the surfaces of the first and second elongate members. In such a manner a single, flexible, multi-lumen tube comprising a main lumen and an inflation lumen may be formed.
According to another aspect of the present invention, the evacuation sheath may be sized to have an outer diameter substantially the same size as the inner diameter of a guide catheter, such as a 6 French guide catheter, alternatively a 7 French guide catheter, alternatively an 8 French guide catheter or any other size guide catheter. In an alternative embodiment, the outer diameter of the evacuation sheath may be covered with a lubricious coating. Additionally, the expandable member of evacuation assembly may also be covered with a lubricious coating.
According to another aspect of the present invention, the evacuation sheath assembly may further include a third elongate tubular member slidably insertable through the main lumen of the first elongate tubular member and extendable from the aperture of the main lumen for positioning beyond the distal end of the main lumen, wherein the third elongate tubular member has a proximal end, a distal end, a lumen extending therebetween. The lumen of the third elongate member further includes an aperture disposed at the distal end for communicating said lumen with the bloodstream and is connected at the proximal end of the tube with an infusion means for delivering a fluid into the blood stream.
According to another aspect of the present invention, a gas inflator for inflating and deflating the expandable member is provided. The gas inflator includes a shuttle mechanism for delivering a bolus of gas to an expandable member via an inflation lumen having one or more outlet ports in communication with the inflation lumen and a high pressure gas source having an inlet port in fluid communication with the shuttle mechanism. The gas inflator may further include a housing and one or more control switches on the housing for controlling gas flow within the inflation lumen, for example an inflation and a deflation button operably connected to the shuttle mechanism. In an alternative embodiment, the gas inflator may further include a mechanism for removing gas from the expandable member, which also may be connected to one or more control switches within the housing. In addition, the gas inflator may further include a tube operably sized to connect with the proximal end of an inflation lumen and place the inflation lumen in fluid communication with the one or more outlet ports.
According to another aspect of the present invention, the gas inflator may further comprise a puncturing mechanism connected to the high pressure gas cartridge, having a puncture spear and a lever for engaging the puncture spear. The high pressure gas cartridge contains a suitable high pressure gas for inflating the expandable member, for example Carbon Dioxide, Nitrous Dioxide or Helium. Additionally, the gas inflator may further comprises an in line filter for sterilizing the gas before delivery to the inflation lumen.
According to another aspect of the present invention, a shuttle mechanism of the gas inflator may be operably connected to inflation and deflation buttons on the housing and may further include a cylindrical shuttle chamber in fluid communication with the one or more outlet ports and the high pressure gas source, wherein a series of seals, for example o-ring seals, are mounted on the shuttle and spaced apart to divide the shuttle chamber into a pressure chamber and a vacuum chamber, wherein the vacuum chamber has a one way bypass seal for venting gas from the vacuum chamber, and a vacuum piston operably connected to the one way bypass seal of the vacuum chamber. The shuttle mechanism further includes translation output connected to the inflation and deflation buttons for moving the shuttle longitudinally within the shuttle chamber to alternately place the vacuum and pressure chambers in fluid communication with a shuttle chamber outlet port and the pressure chamber in fluid communication with a high pressure gas source. In addition, the pressure chamber may further comprise an inlet port in fluid contact with the high pressure gas source for filling the pressure chamber with a bolus of gas. Additionally, the shuttle mechanism may further comprise both a high pressure resistance outlet port and a low pressure resistance outlet port.
In an alternative embodiment, the vacuum chamber may be formed by one o-ring seal and the one-way venting seal spaced apart to define a chamber and the pressure chamber is formed by two or more o-ring seals spaced apart to define a chamber.
In an alternative embodiment, the gas inflator may further comprises a venting system for regulating the pressure of the gas delivered to inflation lumen from the outlet port. Such a venting system may include at least one pressure relief valve for maintaining a constant delivery pressure to the inflation lumen. Alternatively, the venting system may comprise a second pressure release valve. The pressure relief valves may be spring-loaded poppet valves. In addition, one of the pressure relief valves may further comprises a pressure indicator in fluid communication with the inflation lumen, wherein the housing further comprises a window for viewing the pressure indicator.
According to another aspect of the invention, a method for treating a diseased blood vessel is provided. The method includes advancing an elongate tubular member into the blood vessel through the lumen of the guide catheter, positioning the elongate tubular member within the diseased blood vessel, inflating the expandable sealing member located on the distal end of the of the elongate tubular member to form a seal between the region of interest of the diseased blood vessel and the distal end of the guide catheter; and applying a vacuum to the elongate tubular member to cause retrograde blood flow in the blood vessel and to carry fluid into the lumen of the elongate tubular member.
According to another aspect of the invention, a method for treating a diseased blood vessel is provided. The method includes advancing an elongate tubular member into the blood vessel through the lumen of the guide catheter, positioning the elongate tubular member within the diseased blood vessel, inflating the expandable sealing member located on the distal end of the of the elongate tubular member to occlude normal ante grade blood flow in the blood vessel proximal to the region of interest, and applying a vacuum to the elongate tubular member to cause retrograde blood flow in the blood vessel and to carry fluid into the lumen of the elongate tubular member. In addition, the method may further include the step of removing the elongate tubular member from the blood vessel.
According to another aspect of the invention, a method for treating a diseased blood vessel is provided. The method includes advancing a guide catheter proximal to the blood vessel, advancing an elongate tubular member into the blood vessel through the lumen of the guide catheter and beyond the distal opening, wherein the proximal end of the elongate tubular member extends proximally outside the patient during use, positioning the elongate tubular member within the diseased blood vessel, inflating the expandable sealing member located on the distal end of the of the elongate tubular member to occlude normal ante grade blood flow in the blood vessel proximal to the region of interest, and applying a vacuum to the elongate tubular member to cause retrograde blood flow in the blood vessel and to carry fluid into the lumen of the elongate tubular member.
In addition, the method of treating a blood vessel may further include the steps of advancing an infusion catheter through the evacuation lumen and introducing fluid into the blood stream via the infusion catheter while the expandable member is inflated.
In another alternative embodiment, the method of treating a blood vessel may further include the steps of injecting contrast dye through the lumen of the elongate tubular member to verify the occlusion of the blood vessel.
In addition the method of treating a blood vessel may further include the step of applying a second vacuum to the evacuation sheath assembly to re-initiate retrograde flow in the blood vessel and to carry remaining embolic material from the blood vessel into the lumen of the elongate tubular member. In another embodiment, the method may further include the step of applying a vacuum to the gas inflator to deflate the expandable member.
According to another aspect of the present invention the step of inflating the expandable member may further comprises the steps of puncturing a high pressure gas cartridge within the gas inflator, filling a pressure chamber in the gas inflator with a bolus of high pressure gas, depressing a pressure button on the gas inflator to advance a shuttle in the gas inflator, wherein the shuttle transports the pressure chamber into communication with a high pressure resistance output port and wherein the high pressure resistance output port is in communication with the inflation lumen via a tube extending from the gas inflator, regulating the flow of the high pressure gas from the high pressure resistance output port via at least one pressure relief valve, and delivering a low pressure volume of gas to the tube in communication with the inflation lumen and thereby inflating the expandable member.
In an alternative embodiment, the step of inflating the expandable member may also include the step of priming the inflation lumen to remove the ambient air from the inflation lumen and the expandable member prior to advancing the evacuation assembly through the guide catheter. Priming the inflation lumen may further comprise the steps of activating a piston in the gas inflator, wherein the piston in operably connected to a seal with a one way bypass which defines the opening of a vacuum chamber in the gas inflator, releasing the piston and creating a vacuum in a vacuum chamber, depressing a vacuum button on the gas inflator to advance a shuttle mechanism within the gas inflator and place the vacuum chamber in fluid communication with a low pressure resistance output port wherein the low pressure resistance output port is in communication with the inflation lumen, and suctioning the gas from the inflation lumen and the expandable member via the low resistance valve output.
According to another aspect of the present invention the step of deflating the expandable member may further include activating a piston in the gas inflator, wherein the piston in operably connected to a seal with a one way bypass which defines the opening of a vacuum chamber in the gas inflator, releasing the piston and creating a vacuum a vacuum chamber, depressing a vacuum button on the gas inflator to advance a shuttle mechanism within the gas inflator and place the vacuum chamber in fluid communication with a low pressure resistance output port wherein the low pressure resistance output port is in communication with the inflation lumen, suctioning the gas from the inflation lumen and the expandable member via the low resistance valve output.
In an alternative embodiment, the pressure in the inflation lumen may be monitored as the expandable member is being inflated and/or deflated.
Additional objects and advantages of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
The present invention provides a system and method for evacuating emboli, particulate matter and other debris from a blood vessel, and particularly from an occluded blood vessel. As used herein, an “occlusion,” “blockage,” or “stenosis” refers to both complete and partial blockages of the vessels, stenoses, emboli, thrombi, plaque, debris and any other particulate matter which at least partially occludes the lumen of the blood vessel.
This method and apparatus are particularly suited to be used in diseased blood vessels that have particularly fragile lesions, or vessels whereby the consequences of even small numbers of small emboli may be clinically significant. Such blood vessels include diseased SVGs, carotid arteries, coronary arteries with thrombus such as associated with AMI, and renal arteries. However, it is contemplated that the method and apparatus may also be applied to peripheral, neuro, and other vascular and non-vascular applications.
As shown in
In an alternative embodiment, the evacuation sheath assembly may include a third elongate tubular member 140, as depicted in
As shown in
As shown in
It is contemplated that the multi-lumen tube 102 may be sized to fit within a 6 French guide catheter, alternatively a 7 French guide catheter, alternatively an 8 French guide catheter or other sized guide catheters. In an embodiment sized to fit with in a 6 French guide catheter, the main liner tube 107 may have, for example, an inner diameter of 0.052 inches and a wall thickness of 0.0015 inches, alternatively the inner diameter may range from 0.048 to 0.056 inches and/or the wall thickness may range from 0.001 to 0.004 inches. In such an embodiment, the inflation tube 111 may have an inner diameter of 0.006 inches, flattened to an oval shape with an inner diameter of 0.0025 inches and a wall thickness of 0.0015 inches, alternatively, the wall thickness may range from 0.001 to 0.004 inches and/or the inner diameter may range from 0.003 to 0.10 inches which may have no flattening or be flattened to an oval shape with as small as 0.002 inner diameter. In such an embodiment, the encapsulation layer 112 may have a thickness such that the outer diameter of the multi-lumen tube 107 is 0.064 inches, alternatively the outer diameter may range from 0.060-0.070 inches. In an embodiment sized to fit within a 7 French, 8 French or other sized guide catheter, it is further contemplated that ranges for the dimensions of the elements of the multi-lumen tube would be adjusted corresponding to the inner dimension of the guide catheter.
As depicted in
The expandable member 104 is preferably blow-molded and attached to the multi-lumen elongate tubular member 102 with suitable means such as thermal bonding. Further details of preferred balloon materials and methods of fabrication may be found is U.S. patent application Ser. No. 10/214,712, filed on Aug. 9, 2002 and published as US2003/0050600, U.S. patent application Ser. No. 09/8940,896, filed on Aug. 29, 2001 and published as US2002/0165574 and U.S. patent application Ser. No. 09/845,162, filed on May 1, 2001 and published as US2002/0165598 all of which are incorporated in their entirety, herein.
As shown in
In use, the multi-lumen elongate tubular member 102 may be advanced through a guide catheter 204 over a guide wire 202 to extend distally from distal end of the guide catheter 204 into a patients blood vessel 200, in a fashion similar to that described in cross referenced U.S. patent application Ser. No. 10/214,712, Ser. No. 09/8940,896 and Ser. No. 09/845,162 previously incorporated herein by reference. The guide wire 202 preferably only extends initially to the region of interest 206 (e.g. the blockage or lesion), but alternately the guide wire 202 may be advanced beyond the region of interest 206 initially. The multi-lumen elongate tubular member 102 is further advanced until the expandable member 104 is proximal to the region of interest 206. The expandable member may then be expanded to occlude blood flow in the region of interest 206. Once occluded, contrast may be infused via the main lumen 106 into the blood vessel. An inflation syringe 211 may be attached to the manifold 130 of the main lumen 106 via an aspiration tube 131 and stopcock 132 to provide a contrast agent or other fluids, such as saline or therapeutic agents, to the region of interest via the main lumen 106. An interventional catheter such as a stent delivery catheter may be introduced over the guide wire 202, through the main lumen 106 to deliver a stent to the region of interest 206. The interventional catheter may then be removed from the main lumen 106. A vacuum may be induced within the main lumen 106 of the multi-lumen elongate tubular member 102 using a evacuation syringe 210 connected to the main lumen 106 via the stopcock 132 and aspiration tube 131 on the manifold 130. The vacuum will draw the embolic particulate matter 207 from the blood vessel 200 and through the main lumen 106 into the evacuation syringe 210. After the embolic particulate matter is removed, the expandable member 104 may be deflated and the multi-lumen elongate tubular member 102 may be withdrawn from the blood vessel 200. Alternatively, a contrast dye may be introduced into the region of interest via the previously described method to insure that all of the embolic particulate matter was removed and that the region of interest is sufficiently treated before deflating the expandable member and removing the multi-lumen elongate tubular member 102.
An unrecognized advantage of this design, wherein the main lumen 106, which is used for evacuation, extends the full length of the elongate tubular member 102, vs. “short lumen” designs wherein the evacuation lumen was partially defined by the guiding catheter, as described in U.S. patent application Ser. No. 10/214,712, Ser. No. 09/8940,896 and Ser. No. 09/845,162 previously incorporated herein by reference, is that the evacuation lumen is less obstructed. In this embodiment, the full length main lumen typically houses only a guide wire 202 inside, and therefore particulate doesn't catch and hang up on any of the protruding surfaces while being evacuated through the main lumen. In the short lumen designs, the particulate could hang up, particularly at “crossovers” of the guide wire and the proximal shaft and be at risk of redelivery into the circulation during subsequent contrast injections. So even though this design uses the main lumen 106 of the elongate tubular member 102 for the evacuation lumen, which has a smaller full-length cross section for a given guiding catheter compatibility (since none of the main lumen is defined by the guide catheter lumen), it is more effective at particulate removal in the clinical setting.
It is still desirable, however, to maximize the inner diameter of the evacuation lumen 106 to the extent possible, primarily for compatibility with larger stent delivery systems being advanced through the evacuation lumen. For a particular guide catheter compatibility, for example 6 French, 7 French or 8 French, that means making the outer diameter of the elongate tubular member 102 close to the guide catheter inner diameter, adding lubricious coating to the outer surface of the elongate tubular member 102, and making the walls of the elongate tubular member 102 as thin as possible. To help facilitate making the wall thin, a gas instead of liquid is used to inflate the expandable member. Gas has a much lower viscosity than a liquid and therefore enables use of a smaller inflation lumen 110 in the elongate tubular member 102. As shown in
In one embodiment, shown in
The shuttle mechanism 610 of the present embodiment, as depicted in
In use, the shuttle mechanism 610 is transported longitudinally to alternately place the pressure chamber 615 in fluid communication with the cartridge inlet port and then the high resistance outlet 616, as well as the vacuum chamber 613 in fluid communication with the vacuum port 613. As shown in
The outlet port 616 and vacuum port 617 are additionally in fluid communication with at least one pressure relief valve 620. Alternatively, a second pressure relief valve 630 may be provided. Two relief valves provides a safety redundancy in the case of a failure of a single relief valve, however, it is contemplated that a single relief valve could also be utilized. Both relief valves could be similar to the primary relief valve 630 described below, or alternatively, as depicted in
As embodied herein, the indicator relief valve 620 includes an indicator poppet 624, a sealing o-ring 626, a spring 628, and a cap 629. When pressurized gas enters into the pressure relief mechanism, it drives the indicator poppet 624 up, which compresses the spring 628. Once the sealing o-ring rises above the bypass 627 excess gas will leak out, maintaining the gas within the pressure relief mechanism at the desired pressure. In an embodiment as depicted herein, the bypass may be created, for example, by an expansion of the housing to create a gap between the o-ring seal and the housing once the o-ring rises above the expanded section of the housing. The movement of the indicator poppet 624 is also a visual indicator that the pressure relief mechanism (and subsequently the inflation lumen and inflatable member of the catheter) is pressurized, as opposed to being at ambient pressure, or negative vacuum pressure. The pressure at which the indicator relief valve 620 will leak excess gas is determined by the spring stiffness properties, as well as the dimensions of the poppet 624 and sealing o-ring 626. In addition, relatively small adjustments may be made by adjusting the relative tightness of the cap 629, which is screwed onto the housing.
The primary relief valve 630 includes a primary poppet 634, o-ring 636, spring 638, and a cap 639. Unlike the indicator poppet 624, which requires the o-ring to actually rise above the bypass before gas will leak, the primary poppet 634 preferably leaks excess pressurized gas as soon as the poppet 634 begins to move relative to the housing 640. The spring 638 is in a pre-compressed condition against the primary poppet 634 and o-ring 636. When the pressure force on the poppet exceeds the force of the compressed spring 638, the poppet 634 will move slightly, resulting in leakage until the pressure within the primary relief valve drops below the desired pressure.
In use, the desired leak pressure of each relief valve can be the same, or alternatively, the indicator relief valve 620 may be set slightly lower than the primary relief valve 630. In this manner, most or all of the excess pressurized gas will leak from the primary relief valve 630. For example, in an embodiment of the inflation system for use with the embolic protection catheter embodiments described here, the primary relief valve may be set to leak at about ⅔ atmosphere, and the indicator relief valve may be set slightly higher, for example, approximately 0.5 to 1 psi higher.
As previously described, the shuttle mechanism 610 comprises a cylindrical shuttle chamber 612, within which are the shuttle 611 and a series of o-ring seals 614a-e. The shuttle chamber 612 is essentially the annular space between the shuttle and the walls defining the shuttle chamber. For ease in illustration, this “gap” is shown rather large in these figures. The o-rings 614a-e are used to divide the shuttle chamber into two primary chambers, the pressure chamber 615 and the vacuum chamber 613. In addition, the vacuum chamber is further defined by a one-way bypass seal attached to a vacuum piston 664. Three ports access the shuttle chamber, a cartridge inlet port 606 which allows the high pressure gas from the cylinder (not shown) to enter, a high resistance outlet port 616 which conveys the gas from the pressure chamber 613 to the pressure relief mechanism 620 and the expandable member (not shown), and a vacuum port 617 through which gas is drawn out of the expandable member into the vacuum chamber 613 when a vacuum is created.
In
In an alternative embodiment, it may be desirable to “prep” the inflation lumen and expandable member to remove most of the ambient air in the expandable member and all gas passageways, including the inflation lumen, in communication therewith. This additional step of “prepping” the inflation lumen and expandable member is depicted in
To inflate the expandable member with gas, the shuttle mechanism may be moved as shown in
The high resistance outlet 616 controls the flow rate of the high pressure gas from the pressure chamber 615E such that the pressure relief mechanism is not overwhelmed with an excessively high pressure spike. After the expandable member is inflated to the desired target pressure, the pressure chamber, pressure relief mechanism, expandable member and inflation lumen are all at that same relatively low pressure of approximately ⅔ atmosphere, and filled with gas, as noted by the low pressure pattern in the
To deflate the balloon and evacuate the CO2 gas, the evacuation piston is advanced, as shown in
To re-inflate the expandable member, the shuttle 611 is translated again to the left, as shown in
Relative to inflation of the expandable member in the vasculature of the patient, it is preferable to carry out the “prepping” steps depicted in
Having thus described a preferred embodiment of a device and methods for embolic protection during vascular intervention, it should be apparent to those skilled in the art that certain advantages of the within system have been achieved. It should also be appreciated that various modifications, adaptations and alternative embodiments thereof may be made within the scope and spirit of the present invention. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being defined by the following claims.
Number | Name | Date | Kind |
---|---|---|---|
3208467 | Eichelman | Sep 1965 | A |
3886948 | Hakim | Jun 1975 | A |
4228125 | Lobdell et al. | Oct 1980 | A |
4482346 | Reinicke | Nov 1984 | A |
4655746 | Daniels | Apr 1987 | A |
4696668 | Wilcox | Sep 1987 | A |
4784636 | Rydell | Nov 1988 | A |
4883460 | Zanetti | Nov 1989 | A |
4917667 | Jackson | Apr 1990 | A |
4921478 | Solano | May 1990 | A |
4994033 | Shockey et al. | Feb 1991 | A |
5011488 | Ginsburg | Apr 1991 | A |
5019041 | Robinson et al. | May 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5059178 | Ya | Oct 1991 | A |
5074845 | Miraki | Dec 1991 | A |
5108414 | Enderle | Apr 1992 | A |
5137013 | Chiba et al. | Aug 1992 | A |
5169379 | Freed et al. | Dec 1992 | A |
5219355 | Parodi | Jun 1993 | A |
5250060 | Carbo | Oct 1993 | A |
5324260 | O'Neill | Jun 1994 | A |
5350395 | Yock | Sep 1994 | A |
5368566 | Crocker | Nov 1994 | A |
5385562 | Adams et al. | Jan 1995 | A |
5413549 | Leschinsky | May 1995 | A |
5423742 | Theron | Jun 1995 | A |
5451207 | Yock | Sep 1995 | A |
5451233 | Yock | Sep 1995 | A |
5453099 | Lee | Sep 1995 | A |
5459700 | Jacobs | Oct 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5466222 | Ressemann | Nov 1995 | A |
5484412 | Pierpont | Jan 1996 | A |
5486192 | Walinsky et al. | Jan 1996 | A |
5527292 | Adams | Jun 1996 | A |
5533987 | Pray | Jul 1996 | A |
5536242 | Willard | Jul 1996 | A |
5569204 | Cramer | Oct 1996 | A |
5573508 | Thornton | Nov 1996 | A |
5643208 | Parodi | Jul 1997 | A |
5709701 | Parodi | Jan 1998 | A |
5728064 | Burns et al. | Mar 1998 | A |
5728065 | Follmer et al. | Mar 1998 | A |
5738652 | Boyd et al. | Apr 1998 | A |
5749888 | Yock | May 1998 | A |
5755704 | Lunn | May 1998 | A |
5769868 | Yock | Jun 1998 | A |
5779721 | Nash | Jul 1998 | A |
5785685 | Kugler et al. | Jul 1998 | A |
5797949 | Parodi | Aug 1998 | A |
5820594 | Fontirroche et al. | Oct 1998 | A |
5820595 | Parodi | Oct 1998 | A |
5833644 | Zadno-Azizi | Nov 1998 | A |
5833650 | Imran | Nov 1998 | A |
5843022 | Willard | Dec 1998 | A |
5868706 | Cox | Feb 1999 | A |
5879361 | Nash | Mar 1999 | A |
5879499 | Corvi | Mar 1999 | A |
5891090 | Thornton | Apr 1999 | A |
5902290 | Peacock et al. | May 1999 | A |
5913842 | Boyd et al. | Jun 1999 | A |
5916193 | Stevens et al. | Jun 1999 | A |
5938672 | Nash | Aug 1999 | A |
5964223 | Baran | Oct 1999 | A |
5971938 | Hart | Oct 1999 | A |
5989263 | Shmulewitz | Nov 1999 | A |
5997558 | Nash | Dec 1999 | A |
6007545 | Venturelli | Dec 1999 | A |
6013085 | Howard | Jan 2000 | A |
6022336 | Zadno-Azizi | Feb 2000 | A |
6030362 | Boussignac | Feb 2000 | A |
6036715 | Yock | Mar 2000 | A |
6042605 | Martin | Mar 2000 | A |
6080170 | Nash | Jun 2000 | A |
6098405 | Miyata et al. | Aug 2000 | A |
6117124 | Parodi | Sep 2000 | A |
6126635 | Simpson | Oct 2000 | A |
6135991 | Muni | Oct 2000 | A |
6146370 | Barbut | Nov 2000 | A |
6152909 | Bagaisan | Nov 2000 | A |
6156005 | Theron | Dec 2000 | A |
6156010 | Kuracina et al. | Dec 2000 | A |
6159195 | Ha | Dec 2000 | A |
6165158 | Dutta | Dec 2000 | A |
6176844 | Lee | Jan 2001 | B1 |
6206868 | Parodi | Mar 2001 | B1 |
6210363 | Esch et al. | Apr 2001 | B1 |
6228072 | Omaleki | May 2001 | B1 |
6231588 | Zadno-Azizi | May 2001 | B1 |
6234996 | Bagaoisan et al. | May 2001 | B1 |
6270477 | Bagaoisan | Aug 2001 | B1 |
6295989 | Connors, III | Oct 2001 | B1 |
6312407 | Zadno-Azizi | Nov 2001 | B1 |
6355016 | Bagaoisan | Mar 2002 | B1 |
6361637 | Martin | Mar 2002 | B2 |
6398773 | Bagaoisan | Jun 2002 | B1 |
6413235 | Parodi | Jul 2002 | B1 |
6423032 | Parodi | Jul 2002 | B2 |
6454741 | Muni | Sep 2002 | B1 |
6485500 | Kokish | Nov 2002 | B1 |
6497670 | Parodi | Dec 2002 | B1 |
6517515 | Eidenschink | Feb 2003 | B1 |
6520986 | Martin | Feb 2003 | B2 |
6524323 | Nash | Feb 2003 | B1 |
6533800 | Barbut | Mar 2003 | B1 |
6540712 | Parodi | Apr 2003 | B1 |
6544276 | Azizi | Apr 2003 | B1 |
6569147 | Evans | May 2003 | B1 |
6569148 | Bagaoisan | May 2003 | B2 |
6582396 | Parodi | Jun 2003 | B1 |
6589264 | Barbut | Jul 2003 | B1 |
6592546 | Barbut | Jul 2003 | B1 |
6592557 | Barbut | Jul 2003 | B2 |
6595980 | Barbut | Jul 2003 | B1 |
6605074 | Zadno-Aziziz | Aug 2003 | B2 |
6605102 | Mazzocchi | Aug 2003 | B1 |
6623471 | Barbut | Sep 2003 | B1 |
6626886 | Barbut | Sep 2003 | B1 |
6632236 | Hogendijk | Oct 2003 | B2 |
6635029 | Venturelli | Oct 2003 | B1 |
6635046 | Barbut | Oct 2003 | B1 |
6645222 | Parodi | Nov 2003 | B1 |
6652480 | Imran | Nov 2003 | B1 |
6652546 | Nash | Nov 2003 | B1 |
6652565 | Shimada et al. | Nov 2003 | B1 |
6682505 | Bates | Jan 2004 | B2 |
6682543 | Barbut | Jan 2004 | B2 |
6712806 | St. Germain | Mar 2004 | B2 |
6716183 | Clayman et al. | Apr 2004 | B2 |
6733474 | Kusleika | May 2004 | B2 |
6743196 | Barbut | Jun 2004 | B2 |
6746465 | Diederich et al. | Jun 2004 | B2 |
6786888 | Zadno-Azizi | Sep 2004 | B1 |
6790204 | Zadno-Azizi | Sep 2004 | B2 |
6793667 | Hebert et al. | Sep 2004 | B2 |
6805692 | Muni | Oct 2004 | B2 |
6811550 | Holland et al. | Nov 2004 | B2 |
6827701 | MacMahon | Dec 2004 | B2 |
6830577 | Nash | Dec 2004 | B2 |
6830579 | Barbut | Dec 2004 | B2 |
6837881 | Barbut | Jan 2005 | B1 |
6840949 | Barbut | Jan 2005 | B2 |
6843797 | Nash | Jan 2005 | B2 |
6849068 | Bagaoisan | Feb 2005 | B1 |
6855136 | Dorros | Feb 2005 | B2 |
6878128 | MacMahon | Apr 2005 | B2 |
6887220 | Barbut | May 2005 | B2 |
6887227 | Barbut | May 2005 | B1 |
6896663 | Barbut | May 2005 | B2 |
6902540 | Dorros | Jun 2005 | B2 |
6905490 | Parodi | Jun 2005 | B2 |
6905505 | Nash | Jun 2005 | B2 |
6908474 | Hogendijk | Jun 2005 | B2 |
6936056 | Nash | Aug 2005 | B2 |
7402151 | Rosenman et al. | Jul 2008 | B2 |
7771362 | Williams et al. | Aug 2010 | B2 |
7955246 | Lubock et al. | Jun 2011 | B2 |
20010012951 | Bates | Aug 2001 | A1 |
20010037085 | Euteneuer | Nov 2001 | A1 |
20010044598 | Parodi | Nov 2001 | A1 |
20010047184 | Connors, III | Nov 2001 | A1 |
20010049550 | Martin | Dec 2001 | A1 |
20020002397 | Martin | Jan 2002 | A1 |
20020016564 | Courtney | Feb 2002 | A1 |
20020016565 | Zadno-Azizi | Feb 2002 | A1 |
20020022859 | Hogendijk | Feb 2002 | A1 |
20020026145 | Bagaoisan | Feb 2002 | A1 |
20020029031 | Bagaoisan | Mar 2002 | A1 |
20020035347 | Bagaoisan | Mar 2002 | A1 |
20020052638 | Zadno-Azizi | May 2002 | A1 |
20020062119 | Zadno-Azizi | May 2002 | A1 |
20020065507 | Zadno-Azizi | May 2002 | A1 |
20020087119 | Parodi | Jul 2002 | A1 |
20020091407 | Zadno-Azizi | Jul 2002 | A1 |
20020107479 | Bates | Aug 2002 | A1 |
20020151922 | Hogendijk | Oct 2002 | A1 |
20020161395 | Douk | Oct 2002 | A1 |
20020173815 | Hogendijk | Nov 2002 | A1 |
20020177800 | Bagaoisan | Nov 2002 | A1 |
20020188314 | Anderson | Dec 2002 | A1 |
20030009146 | Muni | Jan 2003 | A1 |
20030023200 | Barbut | Jan 2003 | A1 |
20030023204 | Vo | Jan 2003 | A1 |
20030023227 | Zadno-Azizi | Jan 2003 | A1 |
20030040694 | Dorros | Feb 2003 | A1 |
20030040704 | Dorros | Feb 2003 | A1 |
20030040705 | Dorros | Feb 2003 | A1 |
20030040762 | Dorros | Feb 2003 | A1 |
20030055398 | Imran | Mar 2003 | A1 |
20030069549 | MacMahon | Apr 2003 | A1 |
20030083617 | St. Germain | May 2003 | A1 |
20030097036 | St. Germain | May 2003 | A1 |
20030150821 | Bates | Aug 2003 | A1 |
20030158518 | Schonholz | Aug 2003 | A1 |
20030171769 | Barbut | Sep 2003 | A1 |
20030171770 | Kusleika | Sep 2003 | A1 |
20030171771 | Anderson | Sep 2003 | A1 |
20030187390 | Bates | Oct 2003 | A1 |
20030187391 | Hogendijk | Oct 2003 | A1 |
20030187392 | Hogendijk | Oct 2003 | A1 |
20030191434 | Dorros | Oct 2003 | A1 |
20030208222 | Zadno-Azizi | Nov 2003 | A1 |
20030233117 | Adams | Dec 2003 | A1 |
20040010280 | Adams | Jan 2004 | A1 |
20040010282 | Kusleika | Jan 2004 | A1 |
20040015150 | Zadno-Azizi | Jan 2004 | A1 |
20040019310 | Hogendijk | Jan 2004 | A1 |
20040034366 | van der Burg | Feb 2004 | A1 |
20040054347 | Zadno-Azizi | Mar 2004 | A1 |
20040054348 | Hogendijk | Mar 2004 | A1 |
20040064092 | Tsugita | Apr 2004 | A1 |
20040069549 | MacMahon | Apr 2004 | A1 |
20040092869 | Venturelli | May 2004 | A1 |
20040127885 | Barbut | Jul 2004 | A1 |
20040193099 | MacMahon | Sep 2004 | A1 |
20040260239 | Kusleika | Dec 2004 | A1 |
20050004517 | Courtney | Jan 2005 | A1 |
20050004594 | Nool | Jan 2005 | A1 |
20050010247 | Kusleika | Jan 2005 | A1 |
20050020973 | MacMahon | Jan 2005 | A1 |
20050085769 | MacMahon | Apr 2005 | A1 |
20050090854 | Barbut | Apr 2005 | A1 |
20050124849 | Barbut | Jun 2005 | A1 |
20050124973 | Dorros | Jun 2005 | A1 |
20050131453 | Parodi | Jun 2005 | A1 |
20050149112 | Barbut | Jul 2005 | A1 |
20050154298 | Barbut | Jul 2005 | A1 |
20050159640 | Barbut | Jul 2005 | A1 |
Number | Date | Country |
---|---|---|
0427429 | May 1991 | EP |
WO 9742879 | Nov 1997 | WO |
WO 9744082 | Nov 1997 | WO |
WO 9838929 | Sep 1998 | WO |
WO 9838930 | Sep 1998 | WO |
WO 9839046 | Sep 1998 | WO |
WO 9839047 | Sep 1998 | WO |
WO 9908744 | Feb 1999 | WO |
WO 9942059 | Aug 1999 | WO |
WO 9942157 | Aug 1999 | WO |
WO 9945835 | Sep 1999 | WO |
WO 0007657 | Feb 2000 | WO |
WO 0044429 | Aug 2000 | WO |
WO 0051675 | Sep 2000 | WO |
WO 0054673 | Sep 2000 | WO |
WO 0056391 | Sep 2000 | WO |
WO 0076390 | Dec 2000 | WO |
WO 0076390 | Dec 2000 | WO |
WO 0105329 | Jan 2001 | WO |
WO 0112104 | Feb 2001 | WO |
WO 0145590 | Jun 2001 | WO |
WO 0145592 | Jun 2001 | WO |
WO 0158382 | Aug 2001 | WO |
WO 0170326 | Sep 2001 | WO |
WO 0191844 | Dec 2001 | WO |
WO 0222199 | Mar 2002 | WO |
WO 0232495 | Apr 2002 | WO |
WO 03007797 | Jan 2003 | WO |
WO 03008015 | Jan 2003 | WO |
WO 03009880 | Feb 2003 | WO |
WO 2004002564 | Jan 2004 | WO |
WO 2004011058 | Feb 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20070010787 A1 | Jan 2007 | US |